glp 1 is insulin Schematic of action of GLP-1 on secretion GLP-1 Agonists: Increasing Effective Insulin

Do they deepen our bias against fat and make life more miserable draining patients not just of money but also dignity and joy

It's not claiming to replace the drug

R.DiazR.LakshmananM.PaisP.et al (2019)

GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medications that: Slow digestion to reduce appetite Stimulate insulin production to lower blood sugar Promote weight loss (up to 15% of body weight in some cases) Common brands include: Ozempic (semaglutide) for type 2 diabetes Wegovy (semaglutide) for obesity Mounjaro (tirzepatide) for diabetes and weight loss According to the American Diabetes Association, over 8 million Americans now use GLP-1 drugs-and their foot health impacts are significant

However, the regulatory mechanisms of Ca 2+ mobilization by metformin remain obscure, and further investigations are required to confirm the causal relationship with LKB1

A GLP, like Wegovy or Ozempic, or GLP/GIP, like Mounjaro or Zepbound, works by regulating blood sugar, reducing appetite, and slowing digestion